Another study showed that neuron-specific deficiency of RIPK1 or RIPK3 significantly enhances cognitive performance of TBI mice, indicating that RIPK1 or RIPK3 serve as viable therapeutic targets for post-TBI cognitive impairment [57]. This evidence concerns the gene RIPK3 and Cognitive impairment.